Mechanistically, increased PA levels in plasma can induce liver PYCR1 expression to further inhibit the IRS-1/Akt/mTOR signalling pathway and thus exacerbate HFD-induced obesity and metabolic dysfunction. The gene discussed is IRS1; the disease is obesity due to melanocortin 4 receptor deficiency.